H1B Report
H-1B sponsorNYFEIN 11-3259533Updated Sep 2026

BACTOLAC PHARMACEUTICAL INC.

US H-1B Labor Condition Application activity for BACTOLAC PHARMACEUTICAL INC.. Filed 228 disclosures between FY2010 and FY2026 from worksites with a NY headquarters indicator.

Total filings
9
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of BACTOLAC PHARMACEUTICAL INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 97.4%, Cert-withdrawn 0.9%, Withdrawn 1.3%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified97.4%
Cert-withdrawn0.9%
Withdrawn1.3%
Denied0.4%
Certified97.4%
Cert-withdrawn0.9%
Withdrawn1.3%
Denied0.4%

Top occupations sponsored

SOC codes filed most by BACTOLAC PHARMACEUTICAL INC. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201023
FY201127
FY201223
FY201326
FY201416
FY201516
FY201611
FY201716
FY201827
FY20196
FY20232
FY202418
FY20258
FY20269
Time series: 14 points from FY2010 to FY2026
Time series
PeriodValue
FY201023
FY201127
FY201223
FY201326
FY201416
FY201516
FY201611
FY201716
FY201827
FY20196
FY20232
FY202418
FY20258
FY20269

This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.

Compare BACTOLAC PHARMACEUTICAL INC. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.